CDetection.v2: One-pot assay for the detection of SARS-CoV-2

The ongoing 2019 coronavirus disease pandemic (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, is a global public health threat. Early diagnosis and identification of SARS-CoV-2 and its variants plays a critical role in COVID-19 prevention and cont...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2023-03, Vol.14, p.1158163-1158163
Main Authors: Wang, Xinge, Chen, Yangcan, Cheng, Xuejia, Wang, Si-Qi, Hu, Yanping, Feng, Yingmei, Jin, Ronghua, Zhou, Kangping, Liu, Ti, Wang, Jianxing, Pan, Kai, Liu, Bing, Xiang, Jie, Wang, Yanping, Zhou, Qi, Zhang, Ying, Pan, Weiye, Li, Wei
Format: Article
Language:English
Subjects:
clinical samples
CRISPR/Cas12b
Microbiology
molecular diagnosis
one-pot detection platform
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ongoing 2019 coronavirus disease pandemic (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, is a global public health threat. Early diagnosis and identification of SARS-CoV-2 and its variants plays a critical role in COVID-19 prevention and control. Currently, the most widely used technique to detect SARS-CoV-2 is quantitative reverse transcription real-time quantitative PCR (RT-qPCR), which takes nearly 1 hour and should be performed by experienced personnel to ensure the accuracy of results. Therefore, the development of a nucleic acid detection kit with higher sensitivity, faster detection and greater accuracy is important. Here, we optimized the system components and reaction conditions of our previous detection approach by using RT-RAA and Cas12b. We developed a Cas12b-assisted one-pot detection platform (CDetection.v2) that allows rapid detection of SARS-CoV-2 in 30 minutes. This platform was able to detect up to 5,000 copies/ml of SARS-CoV-2 without cross-reactivity with other viruses. Moreover, the sensitivity of this CRISPR system was comparable to that of RT-qPCR when tested on 120 clinical samples. The CDetection.v2 provides a novel one-pot detection approach based on the integration of RT-RAA and CRISPR/Cas12b for detecting SARS-CoV-2 and screening of large-scale clinical samples, offering a more efficient strategy for detecting various types of viruses.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2023.1158163